Meeting Details

The 19th Annual General Meeting was held on Wednesday, September 23, 2026 from 17:00 hrs IST to 18:02 hrs IST (62 minutes duration) through Video Conference/Other Audio-Visual Means (VC/OAVM). The meeting was convened in compliance with the Companies Act, 2013, applicable Rules, Secretarial Standard on General Meetings (SS-2), SEBI (LODR) Regulations, 2015, and relevant circulars from MCA and SEBI.

Attendance

Corporate Office Attendees (Bengaluru):

  • Neeraj Sharma - Chief Executive Officer and Managing Director
  • Anurag Bhagania - Chief Financial Officer
  • Trisha A - Company Secretary and Compliance Officer

Directors Present through VC:

  • Debarati Sen - Independent Director
  • Dr. Claudio Albrecht - Independent Director
  • Colin Bond - Independent Director
  • Dr. Rashmi Barbhaiya - Independent Director
  • Vijay Karwal - Independent Director
  • Bharat D Shah - Non-Executive Director

Other Attendees through VC:

  • G Prakash - Representative & partner of M/s. B S R & Co LLP (proposed Statutory Auditors)
  • Sathya P Koushik - Representative & partner of M/s. Deloitte Haskins & Sells (retiring Statutory Auditors)
  • Nidhi Shree J - Scrutinizer, Partner, M/s. V Sreedharan & Associates
  • Vivek Kumar - Representative & partner of M/s DV & Associates (Secretarial Auditor)

Shareholders: Total 81 shareholders holding 3,46,04,605 shares attended through VC/OAVM. NSDL confirmed requisite quorum.

Resolutions Transacted

The following business items from the AGM notice dated September 23, 2026 were transacted:

1. Re-appointment of Neeraj Sharma (DIN: 09402652) as retiring Director - Ordinary Resolution

2. Appointment and Fixation of Remuneration of Statutory Auditors - Ordinary Resolution (Special Business)

3. Additional Remuneration payable to Neeraj Sharma for FY ended March 31, 2026 - Special Resolution

4. Commission payable to Non-Executive Independent Directors - Special Resolution

5. Approval of material related party transactions with Strides Pharma Science Limited - Ordinary Resolution

6. Approval of material related party transactions with Strides Pharma Inc, USA (WOS of Strides Pharma Science Limited) - Ordinary Resolution

Voting Process

  • Remote e-voting facility was provided by NSDL from Friday, September 18, 2026 (9:00 hours IST) to Tuesday, September 22, 2026 (17:00 hours IST)
  • Shareholders attending the AGM who hadn't voted remotely were provided opportunity to vote during the AGM through NSDL's e-voting facility
  • Nidhi Shree J, Practicing Company Secretary (ICSI Membership No. A71329 and CP:28754), Partner of M/s. V Sreedharan & Associates, was appointed as Scrutinizer to scrutinize both remote e-voting and e-voting during AGM

Key Disclosures

  • Auditor's Report for Consolidated and Standalone Financial Statements for FY ended March 31, 2026 contained no qualifications, observations, adverse remarks or comments
  • Statutory Registers and other documents referred to in AGM Notice were available for electronic inspection
  • Certificate from Secretarial Auditor regarding ESOP Scheme implementation in accordance with SEBI Regulations and shareholders' approval was available for e-inspection

Outcome Declaration

  • E-voting results along with Scrutinizer's Report to be declared within two working days of AGM conclusion (on or before Friday, September 25, 2026)
  • Voting results and scrutinizer's report will be submitted to stock exchanges and made available on company website
  • Trisha A, Company Secretary, was authorized to declare voting results on behalf of the board

Compliance Confirmation

The meeting was confirmed to be conducted in compliance with all applicable laws including Companies Act, 2013, SEBI LODR Regulations, 2015, and Secretarial Standard SS-2.